Emglif-M
Generic Name
Empagliflozin + Metformin Hydrochloride
Indications
Emglif-M is a combination of empagliflozin and metformin hydrochloride indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both empagliflozin and metformin hydrochloride is appropriate. Empagliflozin is indicated to reduce the risk of cardiovascular death in adults with type 2 diabetes mellitus and established cardiovascular disease.
Strength
5mg+1000mg, 12.5mg+500mg & 12.5mg+1000mg
Pack Size
2x7s
Dosage Form
Tablet
Therapeutic Class
ANTI-DIABETIC
Category
Diabetes
